| Product NDC: | 52584-633 |
| Proprietary Name: | Verapamil Hydrochloride |
| Non Proprietary Name: | Verapamil Hydrochloride |
| Active Ingredient(s): | 2.5 mg/mL & nbsp; Verapamil Hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52584-633 |
| Labeler Name: | General Injectables & Vaccines, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075136 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100301 |
| Package NDC: | 52584-633-05 |
| Package Description: | 1 BOX in 1 BAG (52584-633-05) > 1 SYRINGE in 1 BOX > 4 mL in 1 SYRINGE |
| NDC Code | 52584-633-05 |
| Proprietary Name | Verapamil Hydrochloride |
| Package Description | 1 BOX in 1 BAG (52584-633-05) > 1 SYRINGE in 1 BOX > 4 mL in 1 SYRINGE |
| Product NDC | 52584-633 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Verapamil Hydrochloride |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20100301 |
| Marketing Category Name | ANDA |
| Labeler Name | General Injectables & Vaccines, Inc |
| Substance Name | VERAPAMIL HYDROCHLORIDE |
| Strength Number | 2.5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |